Pharmaceutical Electronic Manufacturing Services (EMS) - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

The pharmaceutical electronic manufacturing services (EMS) market is projected to expand from USD 32.69 billion in 2025 and USD 35.17 billion in 2026 to USD 51.91 billion by 2031, registering a CAGR of 8.10% between 2026 and 2031. This report is Segmented by Service Type (PCB Assembly and Integration, and Others), Product Type (Laboratory Automation Electronics, and Others), Application (Biopharmaceutical Manufacturing, and Others), End-User (Pharmaceutical and Biotechnological Companies, and Others), and Geography (North America, Europe, and Others). Value (USD). Market Forecasts Provided in Value (USD).

Global Pharmaceutical Electronic Manufacturing Services (EMS) Market Trends and Insights

Increasing Outsourcing of Pharma Device Manufacturing

The pharmaceutical electronic manufacturing services market is gaining from a steady rise in outsourcing by drug makers that want to keep more capital focused on research programs and product development. Jabil reported 14% growth in its healthcare segment in 2025, and 60% of its new contracts bundled design for manufacturing with supply chain support, which shows that customers are asking for broader services from one partner. This shift changes the role of contract manufacturers because they are now expected to manage documentation, quality routines, and material control instead of only producing boards and assemblies. The pharmaceutical electronic manufacturing services market therefore rewards providers that already operate across more than one regulated site and can move programs without rebuilding every process from the start. Buyers also tend to stay with qualified suppliers longer because switching a validated manufacturing setup creates extra work across engineering, quality, and procurement teams.

Rising Complexity of Drug Delivery Electronics

The pharmaceutical electronic manufacturing services market is also being pushed higher by the growing electronic content inside drug delivery systems, wearable injectors, and connected combination products. These products need tighter integration between electronics, packaging, assembly, and documentation because failure at any point can affect both device performance and product release. Jabil’s February 2025 acquisition of Pharmaceutics International added aseptic filling, lyophilization, and oral solid dose capabilities, which shows how leading suppliers are trying to cover more of the drug device workflow under one operating structure. This kind of expansion supports the pharmaceutical electronic manufacturing services market because customers prefer fewer handoffs when they move from design work into regulated production. Providers that can combine design, validated assembly, and packaging related support are in a stronger position to win longer contracts and protect pricing.

High Capital Intensity for Cleanroom and Automated Assembly Lines

The pharmaceutical electronic manufacturing services market still faces a hard barrier in the cost of building and maintaining regulated electronics capacity. Cleanroom lines, testing systems, environmental controls, and validation support demand more upfront spending than ordinary industrial assembly operations. This burden is heavier in smaller regional markets where financing depth, skilled labor availability, and supporting suppliers are not as strong. The pharmaceutical electronic manufacturing services market therefore remains tilted toward larger firms that can spread compliance and facility costs over bigger production volumes. Smaller providers can still win niche work, but scaling those accounts into broad multi-program relationships is much harder when capital reinvestment stays limited.

Other drivers and restraints analyzed in the detailed report include:

• Tightening Compliance Burden Across ISO, FDA, and EU MDR
• Validation-Ready Digital Traceability and Data Integrity Requirements
• Component Allocation Risk for Miniaturized Medical Electronics

Segment Analysis

PCB assembly and integration held 40.13% of the pharmaceutical electronic manufacturing services market share in 2025, which kept it as the core revenue base across service offerings. This lead comes from the large number of circuit boards used in bioreactor controls, line automation, serialization systems, monitoring devices, and laboratory instruments. Testing and Quality Assurance also remained central because electronics used in pharmaceutical settings need documented performance checks before release into validated operations. In practice, the leading service categories benefit from repeat demand because every expansion in production, packaging, and lab capacity needs dependable assembly and verification work.

Electronic design and engineering is projected to grow at a 10.84% CAGR through 2031, which makes it the fastest-moving service category in the pharmaceutical electronic manufacturing services market. Growth is tied to earlier outsourcing by OEMs that want specialist partners involved before design choices are locked into regulated workflows. Aftermarket Services also form a durable revenue stream because older pharmaceutical equipment still needs board replacement, firmware support, and controlled updates over long operating lives. Across the pharmaceutical electronic manufacturing services industry, this mix shows a clear shift from pure assembly toward broader design, lifecycle support, and compliance-linked services.

Pharmaceutical manufacturing equipment electronics captured 42.27% of 2025 revenue, giving this category the largest position within the pharmaceutical electronic manufacturing services market. The segment stayed ahead because new fill-finish lines, sterile facilities, and oral solid dose plants all require electronics-heavy instrumentation and control hardware. Packaging Line Electronics also showed resilience because serialization, coding, and verification functions keep creating upgrade work across established production lines. These product categories give the pharmaceutical electronic manufacturing services market a large installed base that continues to generate both new build and retrofit demand.

Laboratory automation electronics is forecasted to grow at a 10.96% CAGR through 2031, which makes it the fastest-rising product type. Daiichi Sankyo established a 24-hour automated drug discovery setup in the United States in January 2025, which showed how large research organizations are adopting robot-linked and cloud-connected laboratory environments. This supports the pharmaceutical electronic manufacturing services market because more research automation means more demand for validated boards, sensors, controllers, and integrated assemblies. Smart drug delivery and wearable electronics remain a smaller base today, but their electronics content per device suggests stronger long-run value potential than conventional instrument builds.

Complete Report Scope:

• By Service Type
  • Electronic Design and Engineering Services
  • PCB Assembly and Integration
  • Box Build Assembly
  • Testing and Quality Assurance Services
  • Packaging and Labeling Electronics Integration
  • Aftermarket Services and Maintenance
• By Product Type
  • Control Systems and Automation Electronics
  • Pharmaceutical Manufacturing Equipment Electronics
  • Laboratory Automation Electronics
  • Packaging Line Electronics Systems
  • Other Product Types
• By Application
  • Drug Manufacturing and Production Lines
  • Biopharmaceutical Manufacturing
  • Clinical Research and Laboratory Automation
  • Packaging and Serialization Systems
  • Other Applications
• By End-User
  • Pharmaceutical and Biotechnological Companies
  • Contract Manufacturing Organizations
  • Other End-Users
• By Geography
  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • Middle East and Africa
    • GCC
    • South Africa
    • Rest of Middle East and Africa
  • South America
    • Brazil
    • Argentina
    • Rest of South America

Geography Analysis

North America accounted for 46.36% of the pharmaceutical electronic manufacturing services market share in 2025, which kept it as the largest regional contributor. The region benefits from the highest concentration of regulated electronics contract manufacturers and a mature pharmaceutical customer base. Major investment commitments from AstraZeneca, Eli Lilly, Merck, Johnson & Johnson, and Pfizer continue to support local demand for electronics-intensive manufacturing infrastructure. Canada adds stable mid-market demand, while Mexico is gaining attention as a nearshore assembly base with logistical advantages for U.S.-bound programs.

Asia-Pacific is projected to be the fastest-growing regional block in the pharmaceutical electronic manufacturing services market with 11.24% CAGR through 2031. Growth is being supported by India’s policy push, broader supply chain diversification, and the established precision electronics strengths of Japan and South Korea. This mix gives the region a good position for new capacity, especially where customers want an alternative to single-country sourcing. China remains important for large-volume manufacturing, but higher-value validated work is being redistributed more selectively across the region. That shift should keep India, South Korea, and parts of Southeast Asia relevant to new supplier qualification cycles during the forecast period.

Europe forms the second-largest regional revenue cluster, supported by a strong pharmaceutical production base and active modernization of manufacturing systems. Germany, France, the United Kingdom, Italy, and Spain remain the core demand centers, with Germany especially relevant for control systems and process engineering applications. The Middle East and Africa are still early in development, though Gulf countries are building local pharmaceutical capacity that should lift future electronics demand. South America is led by Brazil and Argentina, but near-term expansion remains constrained by a limited pool of pharma-grade EMS providers and higher qualification costs.

List of Companies Covered in this Report:

• Benchmark Electronics, Inc.
• Celestica
• Creation Technologies LP
• Ensera
• Flex
• Foxconn Technology Group
• Gerresheimer
• Integer Holdings
• Jabil
• Kimball Electronics, Inc.
• MGS Mfg. Group
• Nortech Systems
• Phillips Medisize
• Plexus Corp.
• Sanmina Corporation
• SMC Ltd.
• TE Connectivity Ltd.
• Venture Corporation Limited
• Vexos Inc.
• Zollner Elektronik AG

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support